Mint Tower Capital Management B.V. Moderna, Inc. Transaction History
Mint Tower Capital Management B.V.
- $318 Million
- Q3 2024
A detailed history of Mint Tower Capital Management B.V. transactions in Moderna, Inc. stock. As of the latest transaction made, Mint Tower Capital Management B.V. holds 19,000 shares of MRNA stock, worth $700,150. This represents 0.3% of its overall portfolio holdings.
Number of Shares
19,000Holding current value
$700,150% of portfolio
0.3%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
954Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.56 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.48 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$942 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$621 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$266 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...